Target intelligence / Profile preview

Nicotine (Peripheral Neutralization) (N/A)

Target
N/A
Molecular classification
Ligand-gated ion channel, Receptor
01

Overview

Nicotine’s primary molecular target peripherally is the nicotinic acetylcholine receptor on autonomic ganglia and sensory nerves. Its action leads to neurotransmitter/neuropeptide release causing various physiological responses including cardiovascular stimulation and local irritation. Peripheral neutralization strategies focus on modifying nicotine’s chemical state or blocking its action at these sites—often using organic acids—to reduce unwanted side effects while maintaining efficacy for therapeutic applications like smoking cessation aids.

Other names
Peripheral Nicotinic Acetylcholine Receptor (nAChR)Nicotine Peripheral TargetsPeripheral Nicotine Receptors
02

Mechanism of action

Agonism at nAChRs; possible antagonism via chemical modification

03

Biological functions

NeurotransmissionNeuromodulationIon transportNeurotransmitter releaseSensory nerve activation
04

Disease associations

Nicotine dependenceTobacco-related disorders
05

Safety considerations

Cardiovascular stimulationIrritationNauseaPotential for addictionDevelopment of tolerance
06

Interacting drugs

Nicotine

3 more in the full profile.

Beyond the preview

Go deeper on Nicotine (Peripheral Neutralization) (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotine (Peripheral Neutralization) (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call